Sofinnova wraps up crossover fund at $540m

Sofinnova Partners, a European life sciences venture firm, has closed its crossover fund at $540 million.

3 March 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles